Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Non-Current Assets data on record, last reported at $153.7 million in Q2 2025.

  • For Q2 2025, Non-Current Assets fell 11.14% year-over-year to $153.7 million; the TTM value through May 2025 reached $653.3 million, down 3.2%, while the annual FY2025 figure was $153.7 million, 11.14% down from the prior year.
  • Non-Current Assets reached $153.7 million in Q2 2025 per LFCR's latest filing, roughly flat from $153.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $353.6 million in Q2 2021 and bottomed at $148.2 million in Q1 2023.
  • Average Non-Current Assets over 5 years is $198.1 million, with a median of $169.6 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: surged 159.22% in 2021, then crashed 56.42% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $266.8 million in 2021, then tumbled by 41.19% to $156.9 million in 2022, then rose by 7.78% to $169.1 million in 2023, then rose by 2.62% to $173.5 million in 2024, then dropped by 11.45% to $153.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $153.7 million in Q2 2025, $153.5 million in Q1 2025, and $173.5 million in Q4 2024.